Astrazeneca AZN
NYSE AZN
$166.25 +1.76 (+1.07%)
As of: Aug 21, 2026 · 3:16 PM EDT

Astrazeneca (AZN) Return on Sales (2009 - 2026)

Astrazeneca (AZN) posted quarterly Return on Sales of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and down 99.73% quarter-over-quarter from 0.62% in Q1 2026.

Astrazeneca (AZN) Return on Sales (2009 - 2026) Analysis & Trends

Astrazeneca's Return on Sales history runs 18 years deep, the most recent figure standing at 0.0% for Q2 2026.

  • In Q2 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Jun 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
  • Return on Sales for Q2 2026 stood at 0.0%, down from 0.62% in the prior quarter.
  • The five-year high for Return on Sales was 7.16% in Q2 2024, with the low at 0.0% in Q2 2026.
  • The 5-year median for Return on Sales is 0.3% (2023), against an average of 1.11%.
  • The sharpest annual moves came in 2024 and 2025: Return on Sales surged 704 bps in 2024, then plunged 716 bps in 2025.
  • Astrazeneca's Return on Sales stood at 0.04% in 2022, then surged by 434 bps to 0.22% in 2023, then slumped by 90 bps to 0.02% in 2024, then surged by 21617 bps to 4.88% in 2025, then sank by 100 bps to 0.0% in 2026.
  • Business Quant data shows AZN's Return on Sales at 0.0% in Q2 2026, 0.62% in Q1 2026, and 4.88% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Johnson & Johnson 653.90 Bn 633.14 Bn 17.26 Bn 0.00%
2 AbbVie 470.19 Bn 463.62 Bn 12.70 Bn 0.00%
3 Merck 377.19 Bn 370.05 Bn 12.21 Bn 0.00%
4 Novartis Ag 303.28 Bn 295.59 Bn 11.24 Bn 0.00%
5 Astrazeneca 257.67 Bn 252.77 Bn 12.86 Bn 0.00%
6 Amgen 236.95 Bn 222.96 Bn 7.24 Bn 0.00%
7 Gilead Sciences 182.20 Bn 179.02 Bn 6.22 Bn -0.01%
8 Pfizer 159.32 Bn 147.62 Bn 10.94 Bn 0.00%
9 Gsk 106.10 Bn 101.93 Bn 8.24 Bn 0.00%
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn 0.01%

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00%
Mar 31, 2026 0.62%
Dec 31, 2025 4.88%
Sep 30, 2025 3.59%
Jun 30, 2025 0.00%
Mar 31, 2025 0.52%
Dec 31, 2024 0.02%
Sep 30, 2024 0.38%
Jun 30, 2024 7.17%
Mar 31, 2024 0.76%
Dec 31, 2023 0.22%
Sep 30, 2023 0.20%
Jun 30, 2023 0.12%
Mar 31, 2023 1.01%
Dec 31, 2022 0.04%
Sep 30, 2022 0.01%
Jun 30, 2022 0.45%
Mar 31, 2022 0.03%
Dec 31, 2021 -0.02%
Sep 30, 2021 -0.19%